Frisco City Council approved measures to expand the city’s eligibility for opioid settlement funds at a meeting Aug. 5.
The details
Previous settlement agreements saw Frisco eligible to receive up to $1 million in funds to help address the opioid crisis locally. Several companies are paying out the settlement money to the state, which then distributes it to local municipalities.
The vote Aug. 5 was to add more companies to the settlement and become eligible to receive the additional funds. The additional funding amount has not been specified.
Frisco has received $272,744 to date from the same settlement, which it can use to buy Narcan, a drug that reverses the effects of opioid overdoses. Police officers carry Narcan in the event that they encounter someone overdosing on opioids. The funds can also be used on other things to address the opioid crisis, such as drug collection programs.
The company’s being added to the settlement include:
- Alvogen
- Amneal
- Apotex
- Hikma
- Indivior
- Mylan
- Purdue/Sackler
- Sun
- Zydus
The new settlement amounts to $286.5 million. Between all of the settlements, the state is set to receive almost $3 billion.
The background
In 2021, City Council approved signing on to a settlement agreement with opioid manufacturer Johnson & Johnson, along with three distributors, AmerisourceBergen, Cardinal Health and McKesson
In 2022, the firms Endo/Par and Teva were also added to the settlement agreement. In 2023 and 2024, Allergen, CVS, Walgreens, Walmart and Kroger reached a settlement for their part in the opioid crisis
